Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4533-4542

  Fernández Centeno, Elena ^c   De Ojeda, Gloria ^c   Rojo, José M ^a   Portolés, Pilar ^b  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD28 ANTIGEN; COMPLEMENT RECEPTOR; EPITOPE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; REGULATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION;

EID: 0343134052     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4533     Document Type: Article

References (54)

1. Hebell, T., J. M. Ahearn, and D. Fearon. 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254:102.
2. Heyman, B., E. J. Wiersma, and T. Kinoshita. 1990. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:665.
3. Pepys, M. B. 1974. Role of complement in induction of antibody production in vivo: effect of cobra venom factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. Exp. Med. 140:126.
4. Thyphronitis, G., T. Kinoshita, K. Inoue, J. E. Schweinle, G. C. Tsokos, E. S. Metcalf, F. D. Finkelman, and J. E. Balow. 1991. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immunol. 147:224.
5. Holers, V. M., T. Kinoshita, and H. Molina. 1992. The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function. Immunol. Today 13:231.
6. Liszewski, M. K., T. C. Fairies, D. M. Lublin, I. A. Rooney, and J. P. Atkinson. 1996. Control of the complement system. Adv. Immunol. 61:201.
7. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127.
8. Molina, H., V. M. Holers, B. Li, Y.-F. Fang, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357.
9. Kozono, Y., R. Abe, H. Kozono, R. G. Kelly, T. Azuma, and V. M. Holers. 1998. Cross-linking CD21/CD35 or CD 19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160:1565.
10. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251.
11. Croix, D. A., J. M. Ahearn, A. M. Rosengard, S. Han, G. Kelsoe, M. Ma, and M. C. Carroll. 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183:1857.
12. Molina, H., W. Wong, T. Kinoshita, C. Brenner, S. Foley, and V. M. Holers. 1992. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1. J. Exp. Med. 175:121.
13. Kim, Y.-U.m T. Kinoshita, H. Molina, D. Hourcade, T. Seya, L. M. Wagner, and V. M. Holers. 1995. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 181:151.
14. Li, B., C. Sallee, M. Dehoff, S. Foley, H. Molina, and V. M. Holers. 1993. Mouse Crry/p65: characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 151:4295.
15. Kinoshita, T., G. Thyphronitis, G. C. Tsokos, F. D. Finkelman, K. Hong, H. Sakai, and K. Inoue. 1990. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int. Immunol. 2:651.
16. Kinoshita, T., J. Takeda, K. Hong, H. Kozono, H. Sakai, and K. Inoue. 1988. Monoclonal antibodies to mouse complement receptor type 1 (CR1): their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J. Immunol. 140:3066.
17. Tsujimura, A., K. Shida, M. Kitamura, M. Nomura, J. Takeda, H. Tanaka, M. Matsumoto, K. Matsumiya, A. Okuyama, Y. Nishimune, et al. 1998. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem. J. 330:163.
18. Kameyoshi, Y., M. Matsushita, and H. Okada. 1989. Murine membrane inhibitor of complement which accelerates decay of human C3 convertase. Immunology 68:439.
19. Davis, L. S., S. S. Patel, J. P. Atkinson, and P. E. Lipsky. 1988. Decay-accelerating factor functions as a signal transducing molecule for human T cells. J. Immunol. 141:2246.
20. Cerny, J., H. Stockinger, and V. Horejsi, 1996. Noncovalent associations of T lymphocyte surface proteins. Eur. J. Immunol. 26:2335.
21. + T cell line is activated by syngeneic antigen presenting cells in the absence of antigen. Cell. Immunol. 164:265.
22. Kaye, J., S. Porcelli, J. Tite, B. Jones, and C. A. Janeway, Jr. 1983. Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells. J. Exp. Med. 158:836.
23. Yagi, J., J. Baron, S. Buxser, and C. A. Janeway, Jr. 1990. Bacterial proteins that mediate the association of a defined subset of T cell receptor:CD4 complexes with class II MHC. J. Immunol. 144:892.
24. Galfre, G., S. C. Howe, C. Milstein, G. W. Butcher, and J. C. Howard. 1977. Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 266:550.
25. Ponolés, P., J. Rojo, A. Golby, M. Bonneville, S. Gromkowski, L. Greenbaum, C. A. Janeway, Jr., D. B. Murphy, and K. Bottomly. 1989. Monoclonal antibodies to murine CD3ε define distinct epitopes. one of which may interact with CD4 during T cell activation. J. Immunol. 142:4169.
26. Dialynas, D. P., D. B. Wilde, P. Marrack, A. Pierres, K. Wall, W. Harran, G. Otten, M. Liken, M. Pierres, J. Kappler, et al. 1983. Characterization of the murine antigenic determinant, designated L3T4a. by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol. Rev. 74:29.
27. Ledbetter, J. A., and L. A. Herzenberg. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63.
28. Springer, T. G. Galfre, D. S. Secher, and C. Milstein. 1979. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol. 9:301.
29. Gross, J. A., E. Callas, and J. P. Allison. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149:380.
30. Springer, T., G. Galfre, D. S. Secher, and C. Milstein. 1978. Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation. Eur. J. Immunol. 8:539.
31. Bottomly, K., M. Luqman, L. Greenbaum, S. Carding, J. West, T. Pasqualini, and D. B. Murphy. 1989. A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur. J. Immunol. 19:617.
32. Ohara, J., and W. E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:333.
33. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T-cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
34. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
35. Wigzell, H. 1976. Specific affinity fractionation of lymphocytes using glass or plastic bead columns. Stand. J. Immunol. Suppl. 5:23.
36. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55.
37. Portoles, P., J. M. Rojo, and C. A. J. Janeway. 1990. A simple method for radioactive iodination of CD4 molecules. J. Immunol. Methods 129:105.
38. Janeway, C. A., Jr., J. M. Rojo, K. Saizawa, U. Dianzani, P. Portolés, J. Tite, S. Haque, and B. Jones. 1989. The co-receptor function of murine CD4. Immunol. Rev. 109:77.
39. Schiller, B., C. He, D. J. Salant, A. Lim, J. J. Alexander, and R. J. Quigg. 1998. Inhibition of complement regulation is key to the pathogenesis of Active Heymann Nephritis. J. Exp. Med. 188:1353.
40. fyn. J. Immunol. 149:3515.
41. Karp, C. L., M. Wysocka, L. M. Wahl, J. M. Ahearn, P. J. Cuomo, B. Sherry, G. Trinchieri, and D. E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273:228.
42. Ahearn, J. M., and D. T. Fearon. 1989. Structure and function of the complement receptors CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46:183.
43. Quigg, R. J., Y. Kozono, D. Beithiaume, A. Lim, D. J. Salant, A. Weinfeld, P. Griffin, E. Kremmer, and V. M. Holers. 1998. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J. Immunol. 160:4553.
44. Spicer, A. P., M. F. Seldin, and S. J. Gendler. 1995. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes: duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. J. Immunol. 155:3079.
45. Rudd, C. E. 1996. Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity 4:527.
46. Schwartz, R. H. 1997. T cell clonal anergy. Curr. Opin. Immunol. 9:351.
47. Wange, R. L., and L. E. Samelson. 1996. Complex complexes: signaling at the TCR. Immunity 5:197.
48. Cantrell, D. 1996. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:259.
49. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179.
50. Paul, M. S., M. Aegerter, S. E. O'Brien, C. B. Kurtz, and J. H. Weis. 1989. The murine complement receptor gene family. Analysis of mCRY gene products and their homology to human CR1. J. Immunol. 142:582.
51. Wong, T. C., S. Yant, B. J. Harder, J. K. Korte-Sarfaty, and A. Hirano. 1997. The cytoplasmic domains of complement regulatory protein CD46 interact with multiple kinases in macrophages. J. Leukocyte Biol. 62:892.
52. Manchester, M., J. E. Gairin, J. B. Patlerson, J. Alvarez, M. K. Liszewski, D. S. Eto, J. P. Atkinson, and M. B. A. Oldstone. 1997. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2. Virology 233:174.
53. Okada, N., M. K. Liszewski, J. P. Atkinson, and M. Caparon. 1995. Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc. Natl. Acad Sci. USA 92:2489.
54. Molina, H., C. Brenner, S. Jacobi, J. Gorka, J.-C. Carel, T. Kinoshita, and V. M. Holers. 1991. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. J. Biol. Chem. 266:12173.